Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus

Accumulating evidence suggests that metformin reduces the incidence and mortality of colorectal cancer (CRC). However, underlying mechanisms have not been fully clarified. The aim of this study was to examine the pathological characteristics of resected CRC from patients treated with metformin for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Akira, Kitayama, Joji, Horie, Hisanaga, Koinuma, Koji, Ohzawa, Hideyuki, Yamaguchi, Hironori, Kawahira, Hiroshi, Mimura, Toshiki, Lefor, Alan Kawarai, Sata, Naohiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648042/
https://www.ncbi.nlm.nih.gov/pubmed/32794612
http://dx.doi.org/10.1111/cas.14615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648042/
https://www.ncbi.nlm.nih.gov/pubmed/32794612
http://dx.doi.org/10.1111/cas.14615

Ejemplares similares